Cas:49676-56-4 bis(1h,1h,2h,2h-perfluorooctyl)itaconate manufacturer & supplier

Chemical Name:bis(1h,1h,2h,2h-perfluorooctyl)itaconate

CAS.NO:49676-56-4

Synonyms:bis(1h,1h,2h,2h-perfluorooctyl)itaconate

Molecular Formula:C₂₁H₁₂F₂₆O₄

Molecular Weight:822.27600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:381.764ºC at 760 mmHg

Density:1.584g/cm3

Index of Refraction:1.331

PSA:52.60000

Exact Mass:822.03200

LogP:9.27690

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like bis(1h,1h,2h,2h-perfluorooctyl)itaconate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,bis(1h,1h,2h,2h-perfluorooctyl)itaconate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,bis(1h,1h,2h,2h-perfluorooctyl)itaconate Use and application,bis(1h,1h,2h,2h-perfluorooctyl)itaconate technical grade,usp/ep/jp grade.

Related News: To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early. bis(1h,1h,2h,2h-perfluorooctyl)itaconate manufacturer China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. bis(1h,1h,2h,2h-perfluorooctyl)itaconate supplier For one, people who are surrounded by others of similar body size may not perceive their weight to be outside of the norm and therefore not seek out bariatric surgery,” said Sandon. “[And] there are differences in ethnicities and culture between states with the highest rates of obesity compared to states with lower rates. bis(1h,1h,2h,2h-perfluorooctyl)itaconate vendor China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. bis(1h,1h,2h,2h-perfluorooctyl)itaconate factory Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData��s Company Financials database.